The 14th Five-Year Plan for the development of pharmaceutical industry

I. Background of the preparation of the Plan

The pharmaceutical industry includes chemical pharmaceutical preparations, raw materials, Chinese herbal medicines, proprietary Chinese medicines, biological drugs, auxiliary materials, pharmaceutical equipment, medical equipment, health materials, etc. It is a strategic industry related to the national economy and people's livelihood, economic development and national security, and is an important foundation for the construction of a healthy China.

Since the "13th Five-Year Plan", under the strong leadership of the Party Central Committee and The State Council, under the joint efforts of all parties, China's pharmaceutical industry has made outstanding achievements, the development foundation is more solid, the development momentum is more strong, the overall development level has jumped to a new level, the industrial innovation has made new breakthroughs, the supply security level has been continuously enhanced, and the pace of internationalization has been continuously accelerated. It has made outstanding contributions to the prevention and control of the novel coronavirus epidemic. However, the problems restricting the development of the industry are still prominent, the original innovation capacity of the frontier field is still insufficient, the industrial ecology of coordinated development has not yet formed, the supply risk of small varieties of drugs is still there, the quality control level of generic drugs, traditional Chinese medicine, auxiliary materials and other fields needs to be improved, and the international competitive advantage of high value-added products is not strong.

During the "14th Five-Year Plan" period, the internal and external environment for the development of the pharmaceutical industry faced complex and profound changes. The construction of a healthy China was promoted in an all-round way, and the health service changed from focusing on treatment of diseases to focusing on people's health. A new development pattern with domestic circulation as the main body and international and domestic double circulation promoting each other has been formed, and the domestic pharmaceutical market has entered a stage of high-quality development. A new round of technological change and cross-border integration is accelerating, big data and artificial intelligence are deeply integrated into all aspects of the development of the pharmaceutical industry, and transformative new drug creation technologies, innovative therapies, and new drugs continue to emerge. The new development stage puts forward higher requirements for the pharmaceutical industry, and the pharmaceutical industry needs to accelerate the quality change, efficiency change, and power change to provide strong support for the construction of a new development pattern.

In the face of the new situation and new requirements, in order to promote the transformation of China's pharmaceutical industry to innovation-driven, and accelerate the realization of high-quality development, according to the 14th Five-Year Plan for National Economic and Social Development of the People's Republic of China and the Outline of the 2035 Vision Goals, the Ministry of Industry and Information Technology and nine other departments jointly prepared the Plan.

Ii. Main features of the Plan

1. Coverage was further expanded. Compared with the "Guidelines for the Development of the Pharmaceutical Industry" during the "13th Five-Year Plan" period, the preparation department of the "Plan" added the Department of Emergency Management, the State Medical Insurance Bureau, and the State Administration of Traditional Chinese Medicine, and further enriched the relevant tasks.

2. Focusing on key development tasks On the basis of the national "14th Five-Year Plan" and other important documents, the "Plan" focuses on the high-quality development of the industry, adheres to the problem-oriented, the industrial innovation, industrial chain, supply security, manufacturing capacity, international competition and other key tasks into a separate article, put forward the key tasks to promote the development of the pharmaceutical industry during the "14th Five-Year Plan", and enhance the guidance of the "Plan".

3. Pursuing balanced development and security Since the outbreak of COVID-19, relevant departments have undertaken a number of key tasks in epidemic prevention and control. On the basis of a comprehensive summary of relevant work experience, the "Plan" in-depth study of key work such as medical material security, proposed key tasks such as enhancing supply security capabilities, and compiled columns such as vaccine and shortage of drugs supply security projects.

(4) The outlook to 2035 has been added. According to the current situation of China's pharmaceutical industry innovation ability and the rapid improvement of industrial scale, the Plan carefully analyzes the future development trend, puts forward the long-term goal of China's pharmaceutical industry in 2035, and looks forward to industrial innovation and meeting the needs of the masses.